Epidemiology and treatment of osteoporosis in women: an Indian perspective

Anuradha V Khadilkar, Rubina M Mandlik Growth and Endocrine Unit, Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, Pune, Maharashtra, India Abstract: The number of women with osteoporosis, ie, with reduced bone mass and the disruption of bone architecture, is increasing in I...

Full description

Bibliographic Details
Main Authors: Khadilkar AV, Mandlik RM
Format: Article
Language:English
Published: Dove Medical Press 2015-10-01
Series:International Journal of Women's Health
Online Access:https://www.dovepress.com/epidemiology-and-treatment-of-osteoporosis-innbspwomen-an-indian-persp-peer-reviewed-article-IJWH
id doaj-9db6c418fd0441af86c721d8dd5d7e0c
record_format Article
spelling doaj-9db6c418fd0441af86c721d8dd5d7e0c2020-11-24T23:26:15ZengDove Medical PressInternational Journal of Women's Health1179-14112015-10-012015default84185024205Epidemiology and treatment of osteoporosis in women: an Indian perspectiveKhadilkar AVMandlik RMAnuradha V Khadilkar, Rubina M Mandlik Growth and Endocrine Unit, Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, Pune, Maharashtra, India Abstract: The number of women with osteoporosis, ie, with reduced bone mass and the disruption of bone architecture, is increasing in India. While data on prevalence of osteoporosis among women in India come from studies conducted in small groups spread across the country, estimates suggest that of the 230 million Indians expected to be over the age of 50 years in 2015, 20%, ie, ~46 million, are women with osteoporosis. Thus, osteoporosis is a major public health problem in Indian women. Low calcium intakes with extensive prevalence of vitamin D deficiency, increasing longevity, sex inequality, early menopause, genetic predisposition, lack of diagnostic facilities, and poor knowledge of bone health have contributed toward the high prevalence of osteoporosis. Bone health may be optimized by creating an environment to achieve peak bone mass during adolescence, maintenance of healthy bone throughout the life cycle, and prevention of bone loss postmenopausal. In Indian women, calcium, vitamin D, and bisphosphonates are the commonest first-line therapies used. The use of other drugs such as hormone replacement therapy, estrogen agonists, calcitonin, parathyroid hormone, and denosumab is decided as per the affordability and availability of treatment options. Major gaps still remain in the diagnosis and management of osteoporosis, thus highlighting the need for more structured research in this area. This review focuses on the epidemiology of osteoporosis in Indian women and available treatments. Keywords: osteoporosis, Indian perspective, epidemiology, treatmenthttps://www.dovepress.com/epidemiology-and-treatment-of-osteoporosis-innbspwomen-an-indian-persp-peer-reviewed-article-IJWH
collection DOAJ
language English
format Article
sources DOAJ
author Khadilkar AV
Mandlik RM
spellingShingle Khadilkar AV
Mandlik RM
Epidemiology and treatment of osteoporosis in women: an Indian perspective
International Journal of Women's Health
author_facet Khadilkar AV
Mandlik RM
author_sort Khadilkar AV
title Epidemiology and treatment of osteoporosis in women: an Indian perspective
title_short Epidemiology and treatment of osteoporosis in women: an Indian perspective
title_full Epidemiology and treatment of osteoporosis in women: an Indian perspective
title_fullStr Epidemiology and treatment of osteoporosis in women: an Indian perspective
title_full_unstemmed Epidemiology and treatment of osteoporosis in women: an Indian perspective
title_sort epidemiology and treatment of osteoporosis in women: an indian perspective
publisher Dove Medical Press
series International Journal of Women's Health
issn 1179-1411
publishDate 2015-10-01
description Anuradha V Khadilkar, Rubina M Mandlik Growth and Endocrine Unit, Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, Pune, Maharashtra, India Abstract: The number of women with osteoporosis, ie, with reduced bone mass and the disruption of bone architecture, is increasing in India. While data on prevalence of osteoporosis among women in India come from studies conducted in small groups spread across the country, estimates suggest that of the 230 million Indians expected to be over the age of 50 years in 2015, 20%, ie, ~46 million, are women with osteoporosis. Thus, osteoporosis is a major public health problem in Indian women. Low calcium intakes with extensive prevalence of vitamin D deficiency, increasing longevity, sex inequality, early menopause, genetic predisposition, lack of diagnostic facilities, and poor knowledge of bone health have contributed toward the high prevalence of osteoporosis. Bone health may be optimized by creating an environment to achieve peak bone mass during adolescence, maintenance of healthy bone throughout the life cycle, and prevention of bone loss postmenopausal. In Indian women, calcium, vitamin D, and bisphosphonates are the commonest first-line therapies used. The use of other drugs such as hormone replacement therapy, estrogen agonists, calcitonin, parathyroid hormone, and denosumab is decided as per the affordability and availability of treatment options. Major gaps still remain in the diagnosis and management of osteoporosis, thus highlighting the need for more structured research in this area. This review focuses on the epidemiology of osteoporosis in Indian women and available treatments. Keywords: osteoporosis, Indian perspective, epidemiology, treatment
url https://www.dovepress.com/epidemiology-and-treatment-of-osteoporosis-innbspwomen-an-indian-persp-peer-reviewed-article-IJWH
work_keys_str_mv AT khadilkarav epidemiologyandtreatmentofosteoporosisinnbspwomenanindianperspective
AT mandlikrm epidemiologyandtreatmentofosteoporosisinnbspwomenanindianperspective
_version_ 1725555773494263808